Hepatitis D - 32 Studies Found
RECRUITING |
: Study of Bulevirtide in Participants Who Have Normal or Impaired Liver Function : Chronic Hepatitis D Infection : 2024-09-27 : Administered via subcutaneous injections. |
RECRUITING |
: Study of Hepalatide in Chronic Hepatitis D(CHD) Patients : Chronic Hepatitis D Infection : 2024-09-27 : Either the placebo or hepalatide (2.1 mg, 4.2 mg, or 6.3 mg) will be given for 4 consecutive weeks.s.c., once daily. |